Skip to main content
Book Chapter

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

  • van Dongen C
  • Mac Gillavry M
  • Prins M
John Wiley & Sons, Ltd, (2005)
DOI: 10.1002/14651858.cd003074.pub2
N/ACitations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the initial treatment of venous thromboembolism (VTE) low molecular weight heparin (LMWH) is administered once or twice daily. A once daily treatment regimen is more convenient for the patient and may optimise home treatment. However, it is not clear whether a once daily treatment regimen is as safe and effective as a twice daily treatment regimen.

Cite

CITATION STYLE

APA

van Dongen, C. J., Mac Gillavry, M. R., & Prins, M. H. (2005). Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. In Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. https://doi.org/10.1002/14651858.cd003074.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free